Jessup Wealth Management’s KKR & Co KKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$500K Sell
5,449
-3,058
-36% -$297K 0.15% 57
2026
Q1
$787K Sell
8,507
-70,795
-89% -$7.46M 0.29% 40
2025
Q4
$10.1M Buy
79,302
+1,696
+2% +$211K 3.34% 9
2025
Q3
$10.1M Sell
77,606
-62
-0.1% -$8.8K 3.76% 10
2025
Q2
$10.3M Sell
77,668
-1,182
-1% -$138K 4.15% 7
2025
Q1
$9.12M Buy
78,850
+34,237
+77% +$4.71M 3.83% 8
2024
Q4
$6.6M Sell
44,613
-235
-0.5% -$34.5K 2.81% 15
2024
Q3
$5.86M Buy
44,848
+65
+0.1% +$7.69K 2.69% 14
2024
Q2
$4.71M Sell
44,783
-1,080
-2% -$110K 2.01% 22
2024
Q1
$4.61M Sell
45,863
-3,892
-8% -$358K 1.98% 21
2023
Q4
$4.12M Sell
49,755
-49,104
-50% -$3.32M 2.06% 20
2023
Q3
$6.09M Buy
98,859
+92,072
+1,357% +$5.59M 3.51% 7
2023
Q2
$380K Sell
6,787
-4,440
-40% -$233K 0.2% 47
2023
Q1
$590K Buy
11,227
+3
+0% +$161 0.35% 40
2022
Q4
$521K Buy
+11,224
New +$547K 0.33% 43

Other funds holding KKR

Jessup Wealth Management's KKR Position: Q2 2026 in Review

Jessup Wealth Management reduced its KKR & Co (KKR) stake by 36% in Q2 2026, selling an estimated $297K and leaving 5,449 shares worth $500K. The position accounts for 0.15% of the portfolio, ranked #57.

Jessup Wealth Management first reported a position in KKR in Q4 2022 and has held it in 15 quarters since. The position peaked at $10.3M in Q2 2025. 1,280 funds tracked by Wall St. Rank hold KKR as of Q2 2026.

  • Jessup Wealth Management held 5,449 shares of KKR & Co worth $500K as of Q2 2026.
  • Jessup Wealth Management sold 3,058 KKR & Co shares in Q2 2026, an estimated $297K.
  • KKR & Co made up 0.15% of Jessup Wealth Management's portfolio in Q2 2026, its #57 holding.
  • Jessup Wealth Management first reported a position in KKR & Co in Q4 2022 and has held it in 15 quarters since.
  • Jessup Wealth Management's KKR & Co position peaked at $10.3M in Q2 2025.
  • 1,280 funds tracked by Wall St. Rank held KKR & Co as of Q2 2026.

Based on Jessup Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.